Case report: A case of resistant anti‐SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab

International Journal of Rheumatic DiseasesVolume 27, Issue 3 e15125 LETTER TO THE EDITOR Case report: A case of resistant anti-SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab Maria Farhat, Corresponding Author Maria Farhat [email protected] orcid.org/0009-0003-4375-5489 Dermatology Department, Faculty of Medicine, Saint Joseph University, Hôtel-Dieu de France University Hospital, Beirut, Lebanon Correspondence Maria Farhat, Dermatology Department, Faculty of Medicine, Saint Joseph University, Hôtel-Dieu de France University Hospital, Beirut, Lebanon. Email: [email protected]Search for more papers by this authorBoutros Soutou, Boutros Soutou orcid.org/0000-0002-3906-7021 Dermatology Department, Faculty of Medicine, Saint Joseph University, Hôtel-Dieu de France University Hospital, Beirut, LebanonSearch for more papers by this author Maria Farhat, Corresponding Author Maria Farhat [email protected] orcid.org/0009-0003-4375-5489 Dermatology Department, Faculty of Medicine, Saint Joseph University, Hôtel-Dieu de France University Hospital, Beirut, Lebanon Correspondence Maria Farhat, Dermatology Department, Faculty of Medicine, Saint Joseph University, Hôtel-Dieu de France University Hospital, Beirut, Lebanon. Email: [email protected]Search for more papers by this authorBoutros Soutou, Boutros Soutou orcid.org/0000-0002-3906-7021 Dermatology Department, Faculty of Medicine, Saint Joseph University, Hôtel-Dieu de France University Hospital, Beirut, LebanonSearch for more papers by this author First published: 19 March 2024 https://doi.org/10.1111/1756-185X.15125Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1De Vries M, Schreurs MWJ, Ahsmann EJM, et al. A case of anti-SAE1 dermatomyositis. Case Reports Immunol. 2022; 2022:9000608. 10.1155/2022/9000608 PubMedWeb of Science®Google Scholar 2Albayda J, Mecoli C, Casciola-Rosen L, et al. A north American cohort of anti-SAE dermatomyositis: clinical phenotype, testing, and review of cases. ACR Open Rheumatol. 2021; 3(5): 287-294. 10.1002/acr2.11247 PubMedWeb of Science®Google Scholar 3Hassan N, Davies EJ, Faber BG, Gunawardena H. Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis. Rheumatology. 2021; 60(5): e156-e158. 10.1093/rheumatology/keaa698 PubMedWeb of Science®Google Scholar 4Inoue S, Okiyama N, Shobo M, et al. Diffuse erythema with 'angel wings' sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis. Br J Dermatol. 2018; 179(6): 1414-1415. 10.1111/bjd.17026 CASPubMedWeb of Science®Google Scholar 5Wolstencroft P, Casciola-Rosen L, Fiorentino D. Association between autoantibody phenotype and cutaneous adverse reactions to hydroxychloroquine in dermatomyositis. JAMA Dermatol. 2018; 154(10):1199. 10.1001/jamadermatol.2018.2549 PubMedWeb of Science®Google Scholar 6Gono T, Tanino Y, Nishikawa A, et al. Two cases with autoantibodies to small ubiquitin-like modifier activating enzyme: a potential unique subset of dermatomyositis-associated interstitial lung disease. Int J Rheum Dis. 2019; 22(8): 1582-1586. 10.1111/1756-185X.13593 PubMedWeb of Science®Google Scholar 7Jia E, Wei J, Geng H, et al. Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review. Clin Rheumatol. 2019; 38(8): 2189-2193. 10.1007/s10067-019-04562-w PubMedWeb of Science®Google Scholar Volume27, Issue3March 2024e15125 ReferencesRelatedInformation